Business Description
MDxHealth SA is a diagnostics company focused on prostate cancer and urinary tract infections, offering a range of tests that help doctors make more informed treatment decisions. Their key products include urine and tissue-based tests for prostate cancer detection, a genomic scoring tool for personalized cancer insights, and an antibiotic selection test for urinary infections. The company sells its products across the United States, Europe, and other markets through a dedicated sales team. Founded in 2003 and headquartered in Herstal, Belgium, MDxHealth also works with the University of Oxford on a major prostate cancer research study.
